Airway Management Devices Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Airway Management Devices Market

Airway Management Devices Market by Type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End User (Hospitals, Home care settings) - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 6439 Apr, 2023, by marketsandmarkets.com

The global airway management devices market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.4 billion by 2028, growing at a CAGR of 5.6% from 2022 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the growing demand for airway management devices across developing countries, the rise in surgical procedures, and the increasing prevalence of chronic respiratory disease such as asthma, COPD will drive the growth of the market. On the other hand, lack of reimbursement policies across emerging countries may challenge the growth of market. Whereas, increasing demand for intensive care unit to provide growth opportunities for market.

Attractive Opportunities in the Airway Management Devices Market

Airway Management Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Airway Management Devices Market

Airway Management Devices Market Dynamics

DRIVER: Rising incidence of pre-term births globally

Preterm birth is when a baby is born too early, before 37 weeks of pregnancy have been completed. Globally, there has been a rise in the number of premature births in recent years. Babies with breathing issues may need a mechanical ventilator to help them in breathing. These babies may also develop irregular breathing, apnea, asthma, and other respiratory diseases. Considering these points, the high and rising incidence of pre-term births drives the global demand for airway management devices. To meet the demand of different sizes and shapes of airway management products, vendors are offering products according to infants and pediatric patients’ requirements.

Restraint: Lack of reimbursement policies across emerging countries

Emerging countries have low adoption for expensive airway management devices, due to ineffective reimbursement policies or lack of public health insurance coverage. Such ineffective policies, people need to spend out of pockets which hampers the financial condition of the poor across developing countries, with a lack of support for universal health coverage. Such situations have made countries vulnerable to the risk of chronic diseases. Owing to the high out-of-pocket costs of healthcare, the adoption of expensive medical devices such as video laryngoscopes and advanced surgical procedures is low across emerging countries, that has become a key restraint in the market.

OPPORTUNITY: Rising growth potential in developing countries

Developing countries such as China, India, and Brazil are expected to provide potential growth opportunities to players operating in the market. This is primarily attributed to the large target patient population in India and China. China’s one-child policy has significantly reduced the working-age population in the country and resulted in significant growth in its old age population. Moreover, countries such as India and Malaysia have become medical tourism hubs. The cost of surgical procedures across these developing countries is far less than in developed countries such as the US, Germany, France, and the UK. The resultant rise in surgeries will contribute to the demand for anesthesia procedures and airway management.

CHALLENGE: Dearth of skilled professionals

Airway management procedures such as tracheostomy, endotracheal intubation, and cricothyrotomy procedures require highly skilled anesthetists and trained nurses. The lack of knowledge regarding the right choice of immediate treatment can adversely affect the patient’s condition, can increase the recovery time, and can surge the direct and indirect expenses. Shortage of anesthetists and paramedics has become one of the key concerns for countries across the globe. The shortage has directly impacted the efficiency and capabilities of healthcare settings to provide surgical and emergency care, further hindering the demand for airway management devices used across these procedures.

Airway Management Devices Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of airway management devices. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK

Airway Management Devices Market Ecosystem

In 2022, infraglottic segment to observe highest growth rate of the airway management devices market, by type

Based on the type, the infraglottic segment is expected to observe highest growth during the forecast period. Factors attributing high growth is due to rise in prevalence of cardiovascular diseases, chronic respiratory diseases, and respiratory tract infections are increasing the incidence of acute respiratory failure, thereby driving the demand of intubation procedures and infraglottic devices globally.

In 2022, anesthesia segment is expected to account for the largest share of the airway management devices market, by application.

By application, the anesthesia segment accounted for the largest share during the forecast period. Factors attributing to the large segment of this market include the rising number of surgical interventions. Moreover, the growing need for maintaining a safe breathing passage to lower the risk of anesthesia-related complications during surgery is also driving the use of airway management devices during anesthesia procedures.

The pediatric patient segment of airway management devices market is expected to grow at the highest rate during the forecast period.

The pediatric/neonatal patients segment is expected to grow at the highest CAGR in the market during the forecast period. The rising number of pre-term births globally are driving a rapid demand for airway management across pediatric/neonatal patients.

In 2022, Hospitals segment accounted for the largest share of the airway management devices market, by end user.

The hospital segment accounted for the largest market share during the forecast period. The high share of this segment can be attributed to the increasing number of hospitals and infrastructural & economic development, especially in developing countries. Moreover, the increasing surgical procedure during any surgery also supports high growth in the hospitals segment.

In 2022, North America to dominate in airway management devices market

The global market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to dominate during the forecast period, primarily due to presence of highly developed healthcare system, the increasing prevalence of chronic respiratory diseases, and favorable reimbursement policies for airway management devices.

Airway Management Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The airway management devices market is dominated by players such Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK).

Airway Management Devices Market Report Scope

Report Metrics

Details

Market Revenue in 2022

$1.8 billion

Projected Revenue in 2028

$2.4 billion

Revenue Rate

Poised to grow at a CAGR of 5.6%

Market Driver

Rising incidence of pre-term births globally

Market Opportunity

Rising growth potential in developing countries

This research report categorizes the airway management devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

By Product

  • Imfraglottic Devices
  • Supraglottic Devices
  • Laryngoscopes
  • Resuscitators
  • Cricothyrotomy kits
  • Other Airway Management Devices

By Patient Age

  • Adult Patients
  • Pediatric Patients/Neonates

By Application

  • Anesthesia
  • Emergency Medicine
  • Other applications

By End User

  • Hospitals
  • Ambulatory care settings
  • Home care settings
  • Others

Recent Developments

  • In 2022, SunMed Holdings (US) announced a strategic partnership with Securisyn Medical LLC (US) to enhance ventilated patient safety and broader smooth tube and catheter security.
  • In 2022, Coloplast A/S acquired Atos Medical to add a new chronic business segment – ENT & Respiratory Care, which will run as a separate strategic unit, operating on shared Coloplast infrastructure.
  • In 2022, ICU Medical, Inc. acquired Smiths Medical (US), which includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, it created a leading infusion therapy company.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 35)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 GEOGRAPHICAL SCOPE
           1.2.4 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.4 RESEARCH LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 IMPACT OF ECONOMIC RECESSION ON AIRWAY MANAGEMENT DEVICES MARKET
 
2 RESEARCH METHODOLOGY (Page No. - 40)
    2.1 RESEARCH APPROACH 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Insights from primary experts
                    2.1.2.4 Breakdown of primary participants
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 2 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 3 MARKET: COMPANY REVENUE ESTIMATION
          FIGURE 4 CAGR PROJECTIONS
          FIGURE 5 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN AIRWAY MANAGEMENT MARKET (2023–2028)
    2.3 DATA TRIANGULATION APPROACH 
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: MARKET
 
3 EXECUTIVE SUMMARY (Page No. - 52)
    FIGURE 7 AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 8 MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 9 MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 MARKET FOR LARYNGOSCOPES, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 AIRWAY MARKET, BY PATIENT AGE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET FOR HOSPITALS, BY DEPARTMENT, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL ANALYSIS: MARKET
 
4 PREMIUM INSIGHTS (Page No. - 60)
    4.1 MARKET OVERVIEW 
          FIGURE 16 INCREASING CASES OF CHRONIC RESPIRATORY DISEASES AND GROWING DEVELOPMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    4.2 ASIA PACIFIC: MARKET, BY TYPE 
          FIGURE 17 INFRAGLOTTIC AIRWAY DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
    4.3 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 18 INDIA TO REGISTER HIGHEST REVENUE GROWTH DURING FORECAST PERIOD
    4.4 MARKET, BY REGION (2023–2028) 
          FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING STUDY PERIOD
    4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 65)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 AIRWAY MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 3 MARKET DYNAMICS: MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of chronic respiratory diseases
                                TABLE 4 POPULATION AGED 65 YEARS AND ABOVE, BY REGION (%)
                    5.2.1.2 Growing demand for emergency and intensive care
                    5.2.1.3 Growing incidence of pre-term births globally
                                FIGURE 22 NUMBER OF PRE-TERM BIRTHS (DEVELOPED, LATIN AMERICAN, AND CARIBBEAN COUNTRIES), 1990–2025
                    5.2.1.4 Government support for improving emergency care infrastructure
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of reimbursement policies across developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for single-use airway management devices
                    5.2.3.2 Increased growth potential in emerging countries
                                TABLE 5 COMPARISON OF SURGERY COSTS: INDIA VS. US
           5.2.4 CHALLENGES
                    5.2.4.1 Harmful effects of airway management devices on neonatal patients
                    5.2.4.2 Dearth of skilled professionals for airway management procedures
                    5.2.4.3 Increasing pricing pressure on key market players
 
6 INDUSTRY INSIGHTS (Page No. - 74)
    6.1 INTRODUCTION 
    6.2 INDUSTRY TRENDS 
           6.2.1 USE OF ECO-FRIENDLY AND BIODEGRADABLE POLYMERS IN AIRWAY MANAGEMENT DEVICE MANUFACTURING
    6.3 DEMAND SIDE ANALYSIS 
           6.3.1 GROWING ADOPTION OF ADVANCED INTUBATION TUBE HOLDERS
    6.4 REGULATORY ANALYSIS 
           6.4.1 NORTH AMERICA
                    6.4.1.1 US
                                TABLE 6 US: FDA CLASSIFICATION OF AIRWAY MANAGEMENT DEVICES
                                TABLE 7 US: REGULATORY PROCESS FOR MEDICAL DEVICES
                    6.4.1.2 Canada
           6.4.2 EUROPE
           6.4.3 ASIA PACIFIC
                    6.4.3.1 Japan
                                TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
                    6.4.3.2 China
                                TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION
                    6.4.3.3 India
    6.5 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 10 PORTER’S FIVE FORCES ANALYSIS
           6.5.1 THREAT OF NEW ENTRANTS
           6.5.2 THREAT OF SUBSTITUTES
           6.5.3 BARGAINING POWER OF SUPPLIERS
           6.5.4 BARGAINING POWER OF BUYERS
           6.5.5 INTENSITY OF COMPETITIVE RIVALRY
    6.6 VALUE CHAIN ANALYSIS 
          FIGURE 23 VALUE CHAIN ANALYSIS OF MARKET
    6.7 ECOSYSTEM ANALYSIS 
          FIGURE 24 MARKET: ECOSYSTEM ANALYSIS
           6.7.1 ROLE IN ECOSYSTEM
    6.8 PATENT ANALYSIS 
           6.8.1 PATENT PUBLICATION TRENDS FOR AIRWAY MANAGEMENT DEVICES
                    FIGURE 25 PATENT PUBLICATION TRENDS (JANUARY 1, 2011– APRIL 4, 2023)
           6.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 26 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR AIRWAY MANAGEMENT DEVICES (JANUARY 1, 2011– APRIL 4, 2023)
                    FIGURE 27 TOP APPLICANT COUNTRIES/REGIONS FOR AIRWAY MANAGEMENT DEVICES (JANUARY 1, 2011– APRIL 4, 2023)
 
7 AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE (Page No. - 86)
    7.1 INTRODUCTION 
          TABLE 11 AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
    7.2 INFRAGLOTTIC AIRWAY DEVICES 
          TABLE 12 MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 13 MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 14 MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY REGION, 2021–2028 (MILLION UNITS)
           7.2.1 ENDOTRACHEAL TUBES
                    7.2.1.1 Endotracheal tubes to be most useful devices for airway management
                                TABLE 15 ENDOTRACHEAL TUBES OFFERED BY KEY MARKET PLAYERS
                                TABLE 16 ENDOTRACHEAL TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 17 ENDOTRACHEAL TUBES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.2.2 TRACHEOSTOMY TUBES
                    7.2.2.1 Increased use in ICUs to ensure high adoption of tracheostomy tubes
                                TABLE 18 TRACHEOSTOMY TUBES OFFERED BY KEY MARKET PLAYERS
                                TABLE 19 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 20 TRACHEOSTOMY TUBES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
    7.3 SUPRAGLOTTIC AIRWAY DEVICES 
          TABLE 21 MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 22 MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 23 MARKET FOR SUPRAGLOTTIC AIRWAY MANAGEMENT DEVICES, BY REGION, 2021–2028 (MILLION UNITS)
           7.3.1 LARYNGEAL MASK AIRWAY DEVICES
                    7.3.1.1 Laryngeal mask airway devices to hold largest market share during forecast period
                                TABLE 24 LARYNGEAL MASK AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 25 LARYNGEAL MASK AIRWAY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 26 LARYNGEAL MASK AIRWAY DEVICES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.3.2 OROPHARYNGEAL AIRWAY DEVICES
                    7.3.2.1 Oropharyngeal airway devices to be used in unconscious or unresponsive patients
                                TABLE 27 OROPHARYNGEAL AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 28 OROPHARYNGEAL AIRWAY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 29 OROPHARYNGEAL AIRWAY DEVICES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.3.3 NASOPHARYNGEAL AIRWAY DEVICES
                    7.3.3.1 Easy and effective stimulation of gag reflex to propel segment
                                TABLE 30 NASOPHARYNGEAL AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 31 NASOPHARYNGEAL AIRWAY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 32 NASOPHARYNGEAL AIRWAY DEVICES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.3.4 OTHER SUPRAGLOTTIC AIRWAY DEVICES
                    TABLE 33 OTHER SUPRAGLOTTIC AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS
                    TABLE 34 OTHER SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 OTHER SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
    7.4 LARYNGOSCOPES 
          TABLE 36 MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 37 MARKET FOR LARYNGOSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 38 MARKET FOR LARYNGOSCOPES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.4.1 CONVENTIONAL LARYNGOSCOPES
                    7.4.1.1 Low prices and long history of use to drive segment
                                TABLE 39 CONVENTIONAL LARYNGOSCOPES OFFERED BY KEY MARKET PLAYERS
                                TABLE 40 CONVENTIONAL LARYNGOSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 41 CONVENTIONAL LARYNGOSCOPES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
           7.4.2 VIDEO LARYNGOSCOPES
                    7.4.2.1 High prices of video laryngoscopes to hinder access in developing countries
                                TABLE 42 VIDEO LARYNGOSCOPES OFFERED BY KEY MARKET PLAYERS
                                TABLE 43 VIDEO LARYNGOSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 VIDEO LARYNGOSCOPES MARKET, BY REGION, 2021–2028 (MILLION UNITS)
    7.5 RESUSCITATORS 
           7.5.1 RESUSCITATORS TO BE PREFERRED FOR PEDIATRIC PATIENTS/NEONATES
                    TABLE 45 RESUSCITATORS OFFERED BY KEY MARKET PLAYERS
                    TABLE 46 MARKET FOR RESUSCITATORS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 47 MARKET FOR RESUSCITATORS, BY REGION, 2021–2028 (MILLION UNITS)
    7.6 CRICOTHYROTOMY KITS 
           7.6.1 RISING NUMBER OF TRAFFIC ACCIDENTS AND RELATED HEAD AND NECK INJURIES TO PROPEL MARKET
                    TABLE 48 CRICOTHYROTOMY KITS OFFERED BY KEY MARKET PLAYERS
                    TABLE 49 MARKET FOR CRICOTHYROTOMY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 50 MARKET FOR CRICOTHYROTOMY KITS, BY REGION, 2021–2028 (MILLION UNITS)
    7.7 OTHER AIRWAY MANAGEMENT DEVICES 
          TABLE 51 OTHER AIRWAY MANAGEMENT DEVICES OFFERED BY KEY MARKET PLAYERS
          TABLE 52 MARKET FOR OTHER AIRWAY MANAGEMENT DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE (Page No. - 117)
    8.1 INTRODUCTION 
          TABLE 53 MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
    8.2 ADULT PATIENTS 
           8.2.1 ADULTS PATIENTS TO HOLD LARGEST SHARE OF MARKET DURING STUDY PERIOD
                    FIGURE 28 AGE-ADJUSTED PREVALENCE OF COPD (2011–2020)
                    TABLE 54 MARKET FOR ADULT PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 PEDIATRIC PATIENTS/NEONATES 
           8.3.1 AGE-RELATED DIFFERENCES IN ANATOMY AND PHYSIOLOGY TO HINDER AIRWAY MANAGEMENT
                    TABLE 55 MARKET FOR PEDIATRIC PATIENTS/NEONATES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION (Page No. - 122)
    9.1 INTRODUCTION 
          TABLE 56 AIRWAY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 ANESTHESIA 
           9.2.1 ANESTHESIA TO HOLD LARGEST SHARE OF AIRWAY MANAGEMENT DEVICES APPLICATIONS MARKET DURING STUDY PERIOD
                    TABLE 57 MARKET FOR ANESTHESIA, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 EMERGENCY MEDICINE 
           9.3.1 RESUSCITATORS AND SUPRAGLOTTIC AIRWAY MANAGEMENT DEVICES TO BE USED IN INITIAL PHASES OF EMERGENCY CARE
                    TABLE 58 MARKET FOR EMERGENCY MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 OTHER APPLICATIONS 
          TABLE 59 MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 AIRWAY MANAGEMENT DEVICES MARKET, BY END USER (Page No. - 127)
     10.1 INTRODUCTION 
             TABLE 60 MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.2 HOSPITALS 
             TABLE 61 MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             TABLE 62 MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
             10.2.1 OPERATING ROOMS
                        10.2.1.1 Rising number of surgeries to drive demand for airway management devices in operating rooms
                                     TABLE 63 US: INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED
                                     TABLE 64 OPERATING ROOMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             10.2.2 EMERGENCY CARE DEPARTMENTS
                        10.2.2.1 Increased number of emergencies and trauma care patients to propel market
                                     TABLE 65 EMERGENCY CARE DEPARTMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             10.2.3 INTENSIVE CARE UNITS
                        10.2.3.1 Rising disease prevalence and growing need for monitoring to fuel segment
                                     TABLE 66 INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 AMBULATORY CARE CENTERS 
             10.3.1 HIGH COSTS IN HOSPITAL OUTPATIENT DEPARTMENTS TO INCREASE FOCUS ON AMBULATORY CARE
                        TABLE 67 MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 HOME CARE SETTINGS 
             10.4.1 RISING AWARENESS AND ACCEPTANCE OF HOME CARE TO BOOST MARKET
                        TABLE 68 MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 OTHER END USERS 
             TABLE 69 MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 AIRWAY MANAGEMENT DEVICES MARKET, BY REGION (Page No. - 138)
     11.1 INTRODUCTION 
             FIGURE 29 AIRWAY MARKET: GEOGRAPHICAL SNAPSHOT (2022)
             TABLE 70 AIRWAY MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
                        FIGURE 30 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET SNAPSHOT
                        TABLE 71 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 72 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 73 NORTH AMERICA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 74 NORTH AMERICA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 75 NORTH AMERICA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 76 NORTH AMERICA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 77 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 78 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 79 NORTH AMERICA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.2.2 US
                        11.2.2.1 US to dominate North American market during forecast period
                                      TABLE 80 US: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 81 US: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 82 US: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 83 US: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 84 US: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 85 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 86 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 87 US: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing government focus on local manufacturing of medical devices to propel market
                                      TABLE 88 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 89 CANADA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 90 CANADA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 91 CANADA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 92 CANADA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 93 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 94 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 95 CANADA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
                        FIGURE 31 EUROPE: AIRWAY MARKET SNAPSHOT
                        TABLE 96 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 97 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 98 EUROPE: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 99 EUROPE: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 100 EUROPE: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 101 EUROPE: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 102 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 103 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 104 EUROPE: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Germany dominated European airway management devices market in 2022
                                      TABLE 105 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 106 GERMANY: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 107 GERMANY: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 108 GERMANY: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 109 GERMANY: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 110 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 111 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 112 GERMANY: MARKET, FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Presence of advanced and well-established healthcare system to fuel market
                                      TABLE 113 FRANCE: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 114 FRANCE: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 115 FRANCE: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 116 FRANCE: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 117 FRANCE: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 118 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 119 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 120 FRANCE: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.4 UK
                        11.3.4.1 High prevalence of respiratory disorders to drive demand for airway management devices in healthcare settings
                                      TABLE 121 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 122 UK: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 123 UK: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 124 UK: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 UK: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 126 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 127 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 128 UK: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Rising surgical volumes to augment demand for general anesthesia and airway management
                                      TABLE 129 ITALY: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 130 ITALY: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 131 ITALY: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 132 ITALY: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 133 ITALY: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 134 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 135 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 136 ITALY: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Aging population and increasing prevalence of respiratory diseases to aid market
                                      TABLE 137 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 SPAIN: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 SPAIN: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 SPAIN: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 141 SPAIN: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 142 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 143 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 144 SPAIN: MARKET, FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 145 REST OF EUROPE: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 146 REST OF EUROPE: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 147 REST OF EUROPE: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 148 REST OF EUROPE: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 149 REST OF EUROPE: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 150 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 151 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 152 REST OF EUROPE: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
                        FIGURE 32 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET SNAPSHOT
                        TABLE 153 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 154 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 155 ASIA PACIFIC: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 156 ASIA PACIFIC: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 157 ASIA PACIFIC: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 158 ASIA PACIFIC: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 159 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 160 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 161 ASIA PACIFIC: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Strong healthcare system and favorable reimbursement policies to support market
                                      TABLE 162 JAPAN: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 JAPAN: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 164 JAPAN: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 165 JAPAN: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 166 JAPAN: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 167 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 168 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 169 JAPAN: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Growing number of healthcare facilities and policy reforms to stimulate market
                                      TABLE 170 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 171 CHINA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 172 CHINA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 173 CHINA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 174 CHINA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 175 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 176 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 177 CHINA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Increasing prevalence of respiratory diseases and pre-term births to drive demand for airway management devices
                                      TABLE 178 INDIA: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 179 INDIA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 180 INDIA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 181 INDIA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 182 INDIA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                                      TABLE 183 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 184 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 185 INDIA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 186 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 187 REST OF ASIA PACIFIC: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 188 REST OF ASIA PACIFIC: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 189 REST OF ASIA PACIFIC: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 190 REST OF ASIA PACIFIC: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 191 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 192 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 193 REST OF ASIA PACIFIC: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 FAVORABLE REIMBURSEMENT SCENARIOS AND HEALTHCARE DEVELOPMENT INITIATIVES TO BOOST MARKET
             11.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
                        TABLE 194 LATIN AMERICA: AIRWAY MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 195 LATIN AMERICA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 196 LATIN AMERICA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 197 LATIN AMERICA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 198 LATIN AMERICA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 199 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 200 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 201 LATIN AMERICA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 IMPROVING HEALTH INFRASTRUCTURE AND MANDATORY HEALTH INSURANCE TO SUPPORT MARKET
             11.6.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
                        TABLE 202 MIDDLE EAST & AFRICA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 203 MIDDLE EAST & AFRICA: MARKET FOR INFRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 204 MIDDLE EAST & AFRICA: MARKET FOR SUPRAGLOTTIC AIRWAY DEVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 205 MIDDLE EAST & AFRICA: MARKET FOR LARYNGOSCOPES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 206 MIDDLE EAST & AFRICA: MARKET, BY PATIENT AGE, 2021–2028 (USD MILLION)
                        TABLE 207 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 208 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 209 MIDDLE EAST & AFRICA: MARKET FOR HOSPITALS, BY DEPARTMENT, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 210)
     12.1 OVERVIEW 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
     12.3 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN AIRWAY MANAGEMENT DEVICES MARKET 
     12.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 33 REVENUE ANALYSIS OF TOP PLAYERS IN MARKET
     12.5 MARKET SHARE ANALYSIS 
             FIGURE 34 MARKET SHARE, BY KEY PLAYER, 2022
     12.6 COMPANY EVALUATION QUADRANT 
             12.6.1 STARS
             12.6.2 EMERGING LEADERS
             12.6.3 PERVASIVE PLAYERS
             12.6.4 PARTICIPANTS
                        FIGURE 35 AIRWAY MARKET: COMPANY EVALUATION QUADRANT (2022)
     12.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 
             12.7.1 PROGRESSIVE COMPANIES
             12.7.2 DYNAMIC COMPANIES
             12.7.3 STARTING BLOCKS
             12.7.4 RESPONSIVE COMPANIES
                        FIGURE 36 AIRWAY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2022)
     12.8 COMPANY PRODUCT FOOTPRINT 
             12.8.1 TYPE FOOTPRINT
                        TABLE 210 MARKET: TYPE FOOTPRINT
             12.8.2 END USER FOOTPRINT
                        TABLE 211 MARKET: END USER FOOTPRINT
             12.8.3 REGIONAL FOOTPRINT
                        TABLE 212 AIRWAY MANAGEMENT DEVICES MARKET: REGIONAL FOOTPRINT
     12.9 COMPETITIVE SCENARIO 
             12.9.1 KEY PRODUCT LAUNCHES AND APPROVALS
                        TABLE 213 KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019–APRIL 2023
             12.9.2 KEY DEALS
                        TABLE 214 KEY DEALS, JANUARY 2019–APRIL 2023
             12.9.3 OTHER KEY DEVELOPMENTS
                        TABLE 215 OTHER KEY DEVELOPMENTS, JANUARY 2019–APRIL 2023
 
13 COMPANY PROFILES (Page No. - 225)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 MEDTRONIC
                        TABLE 216 MEDTRONIC: COMPANY OVERVIEW
                        FIGURE 37 MEDTRONIC: COMPANY SNAPSHOT (2022)
             13.1.2 ICU MEDICAL, INC.
                        TABLE 217 ICU MEDICAL, INC.: COMPANY OVERVIEW
                        FIGURE 38 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022)
             13.1.3 TELEFLEX INCORPORATED
                        TABLE 218 TELEFLEX INCORPORATED: COMPANY OVERVIEW
                        FIGURE 39 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
             13.1.4 AMBU A/S
                        TABLE 219 AMBU A/S: COMPANY OVERVIEW
                        FIGURE 40 AMBU A/S: COMPANY SNAPSHOT (2022)
             13.1.5 CONVATEC GROUP PLC
                        TABLE 220 CONVATEC GROUP PLC: COMPANY OVERVIEW
                        FIGURE 41 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2022)
             13.1.6 KARL STORZ SE & CO. KG
                        TABLE 221 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
             13.1.7 FLEXICARE (GROUP) LIMITED
                        TABLE 222 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW
             13.1.8 INTERSURGICAL LTD.
                        TABLE 223 INTERSURGICAL LTD.: COMPANY OVERVIEW
             13.1.9 SUNMED LLC
                        TABLE 224 SUNMED LLC: COMPANY OVERVIEW
             13.1.10 VYAIRE
                        TABLE 225 VYAIRE: COMPANY OVERVIEW
             13.1.11 VBM MEDIZINTECHNIK GMBH
                        TABLE 226 VBM MEDIZINTECHNIK GMBH: COMPANY OVERVIEW
             13.1.12 VERATHON INC.
                        TABLE 227 VERATHON INC.: COMPANY OVERVIEW
                        FIGURE 42 ROPER TECHNOLOGIES: COMPANY SNAPSHOT (2022)
             13.1.13 SOURCEMARK
                        TABLE 228 SOURCEMARK: COMPANY OVERVIEW
             13.1.14 MERCURY ENTERPRISES
                        TABLE 229 MERCURY ENTERPRISES: COMPANY OVERVIEW
             13.1.15 ATOS MEDICAL
                        TABLE 230 ATOS MEDICAL: COMPANY OVERVIEW
                        FIGURE 43 COLOPLAST GROUP: COMPANY SNAPSHOT (2022)
             13.1.16 P3 MEDICAL
                        TABLE 231 P3 MEDICAL: COMPANY OVERVIEW
             13.1.17 HENAN TUOREN MEDICAL DEVICE CO., LTD.
                        TABLE 232 HENAN TUOREN MEDICAL DEVICE CO., LTD: COMPANY OVERVIEW
             13.1.18 MEDEREN NEOTECH LTD.
                        TABLE 233 MEDEREN NEOTECH LTD: COMPANY OVERVIEW
             13.1.19 BOMIMED
                        TABLE 234 BOMIMED: COMPANY OVERVIEW
             13.1.20 MEDIS MEDICAL (UK) LTD.
                        TABLE 235 MEDIS MEDICAL (UK) LTD.: COMPANY OVERVIEW
     13.2 OTHER PLAYERS 
             13.2.1 OLYMPUS CORPORATION
             13.2.2 ARMSTRONG MEDICAL LTD. (EAKIN HEALTHCARE GROUP)
             13.2.3 NIHON KOHDEN CORPORATION
             13.2.4 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.
             13.2.5 VENNER MEDICAL MEDIZINTECHNIK
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 286)
     14.1 INSIGHTS FROM INDUSTRY EXPERTS 
     14.2 DISCUSSION GUIDE 
     14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.4 CUSTOMIZATION OPTIONS 
     14.5 RELATED REPORTS 
     14.6 AUTHOR DETAILS 

The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as acquisitions, product launches, expansions, collaborations, agreements and partnerships of the leading players, the competitive landscape of the electrophoresis market to analyzes market players on various parameters within the broad categories of business and product strategy. Revenue share analysis were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the electrophoresis market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the airway management devices market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such clinical laboratories, hospitals, and academic & research institutes) and supply-side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Airway Management Devices Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Total Market Size: Global Airway Management Devices Market

The total size of the market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Approach 1: Airway Management Devices Market - Revenue Share Analysis

  • Revenues for individual companies were gathered from public sources and databases for each market segment.
  • Shares of the airway management products of the leading players were gathered respectively from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, and geographic reach.
  • Individual shares or revenue estimates were validated through Interviews with Experts.
  • The market size was then extrapolated to obtain the global market. It was further validated through Interviews with Experts.

The following figure shows an illustrative representation of the overall market size estimation process employed for this study.

Market Size Estimation: Revenue Share Analysis

Airway Management Devices Market Size, and Share

Source: Annual Reports, SEC Filings, Investor Presentations, Secondary Research, Interviews with Experts, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Airway Management Devices Market: Company Revenue Estimation

Airway Management Devices Market Size, and Share

Source: Annual Reports, SEC Filings, Investor Presentations, Secondary Research, Interviews with Experts, and MarketsandMarkets Analysis

Approach 2: Primary Interviews

  • As a part of the primary research process, individual respondents’ insights on the market size and market growth were taken during the interview (regional and global, as applicable).
  • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Market Definition

Healthcare professionals use airway management devices to clear or bypass obstructed airways to maintain and restore ventilation. An obstructed airway can usually result from anesthesia, respiratory infections, anatomical abnormalities, trauma, or foreign matter that blocks the breathing passage.

Key Stakeholders

  • Manufacturing Companies of Airway Management Devices
  • Hospitals
  • Group Purchase Organizations
  • Ambulatory Care Centers
  • Assisted Living Facilities/Home Healthcare Service Providers.
  • Healthcare Insurance Providers
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Report Objective

  • To define, describe, segment, and forecast the airway management devices market by type, application, patient age, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market with respect to the five key regions (along with countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product launches & enhancements, expansions, mergers & acquisitions, partnerships, contracts, and collaborations

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of the Asia Pacific market into South Korea, Australia, and others
  • Further breakdown of the Latin American market into Brazil, Mexico, and others

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 6439
Published ON
Apr, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Airway Management Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback